Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,628 across all filing types
Latest filing 2008-06-10 Capital/Financing Update
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT - PRICE SENSITIVE INFORMATION AND RESUMPTION OF TRADING
Capital/Financing Update Classification · 95% confidence The document is an announcement made pursuant to Rule 13.09(1) of the Listing Rules of the Stock Exchange of Hong Kong. It details a state-assets transfer agreement involving the sale and purchase of share capital between related companies, the impact on shareholding structure, and the resumption of trading after suspension. It discusses the acquisition and shareholding changes but does not contain financial statements or detailed financial performance data. The document is a formal announcement about a corporate transaction and trading status, not a full financial report or earnings release. It also references compliance with the Takeovers Code and a waiver granted by the Securities and Futures Commission. The content fits best under Capital/Financing Update (CAP) as it relates to changes in ownership and share capital structure due to acquisitions and share transfer agreements. The document length (8015 characters) and detailed content support this classification rather than a brief announcement or regulatory filing. Therefore, the filing type is CAP with high confidence.
2008-06-10 English
SUSPENSION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading of the company's shares pending the release of an announcement about a proposed restructuring of its ultimate controlling shareholders. It does not contain financial data, detailed report content, or regulatory certifications. It is an official regulatory announcement related to trading status and shareholder structure but does not fit into categories like Annual Report, Earnings Release, or Management Reports. Given its nature as a regulatory announcement about trading suspension and pending price-sensitive information, it best fits the category of Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification, so RNS is appropriate.
2008-06-10 English
EXCHANGE NOTICE - SUSPENSION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short notice from an exchange regarding the suspension of trading for a specific company's shares. It does not fit into specific categories like M&A, earnings, or dividends, and it is not a full report. As it is a general regulatory announcement regarding trading status, it falls under the RNS category.
2008-06-10 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding the resumption of trading for a specific stock code. It does not contain financial statements, management reports, or other substantive disclosures, but rather serves as a regulatory notification regarding market activity. As it does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing category.
2008-06-05 English
MAJOR AND CONNECTED TRANSACTION: ACQUISITION OF 51% EQUITY INTEREST AND THE SHAREHOLDER'S LOAN IN OCT INVESTMENTS LIMITED AND RESUMPTION OF TRADING
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a major and connected transaction involving the acquisition of a 51% equity interest and shareholder's loan in OCT Investments Limited by Overseas Chinese Town (Asia) Holdings Limited. It details the terms of the acquisition, consideration, conditions precedent, and the resumption of trading. The content focuses on the transaction specifics, share issuance, and regulatory compliance under the Listing Rules. There is no presentation of financial statements or detailed financial performance data typical of an Annual Report or Interim Report. The document is not a proxy solicitation, voting results, or management change announcement. It is a formal announcement of a significant corporate transaction and financing arrangement involving share issuance as consideration. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2008-06-05 English
SUSPENSION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading of the company's shares pending the release of an announcement related to a major and connected transaction. It does not contain financial data, detailed transaction information, or the actual announcement of the transaction itself. The document is brief (980 characters) and serves as a notification rather than a full report or detailed filing. According to the classification rules, such brief announcements about trading suspension pending a major transaction announcement fall under Regulatory Filings (RNS) as a general regulatory announcement and do not qualify as a M&A Activity (TAR) or Capital/Financing Update (CAP) since it does not provide substantive details of the transaction or financing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2008-06-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.